DS was established from the merger of Daiichi Pharmaceutical and Sankyo in 2005. As of 2021, we estimate over 60% of DS’ revenue comes from lucrative business lines, such as pain medication ...

Daiichi won approval for Turalio on the strength of a 120-patient study that reported response rates of 39% for the study ...

A Welsh mum with incurable breast cancer is unable to access a life-extended drug as it is only available in Scotland.

Datopotamab deruxtecan is a specifically engineered TROP2-directed DXd antibody drug conjugate discovered by Daiichi Sankyo and being jointly developed by AstraZeneca and Daiichi Sankyo. AstraZeneca ...

Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

She recognises them as the drugs she prescribes daily to men, women, and children living with HIV, dispensed from her office in the modest, tin-roofed HIV clinic at the Nkhoma hospital.

A woman who suffered years of pain because of a life-threatening genetic disorder says a new clinical trial has "changed my life". Sian Harding, from Benfleet in Essex was born with a rare ...

Abigail Kavanagh, 25, of Ely, Cardiff, was sentenced at Newport Crown Court on October 22 for her role in trafficking the drugs on behalf of an organised crime group Credit: South Wales Police/PA ...

As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...